Trinidad & Tobago Wellness Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Trinidad & Tobago Wellness Today.

Press releases published on September 23, 2026

4 hours ago

Actinogen XanaMIA pivotal Alzheimer’s disease trial completes final patient visit, with topline results on track for November

Indeterminate GlobeNewswire

4 hours ago

Moleculin Biotech Secures Mexican Patent Protecting Lung-Targeted Liposomal Annamycin Through 2040

Indeterminate GlobeNewswire

4 hours ago

MaxCyte Appoints Sidharth Kapileshwar as Chief Corporate Development Officer

Indeterminate GlobeNewswire

4 hours ago

Monogram Health Appoints James Lim as Chief Technology Officer

Indeterminate GlobeNewswire

4 hours ago

ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor

Indeterminate GlobeNewswire

4 hours ago

SOTIO Advances SOT106 with Dual FDA Designations, Further Positioning the Program as a Potential Best-in-Class ADC for Sarcoma

Indeterminate GlobeNewswire

4 hours ago

Annovis Announces Partnership with Weave Bio, AI Regulatory Platform, in Preparation of NDA for Buntanetap in Alzheimer’s Disease

Indeterminate GlobeNewswire

4 hours ago

Tempest Appoints Global Finance Leader Nancy Freda-Smith to Board of Directors

Indeterminate GlobeNewswire

4 hours ago

BioAro Launches AI-Assisted LONgevity+™ Bioactives in the U.S. and U.K.

Indeterminate GlobeNewswire

4 hours ago

PhAST Corp. Receives FDA Clearance for Rapid Antimicrobial Susceptibility Testing Directly From Positive Blood Cultures

Indeterminate GlobeNewswire

4 hours ago

Altimmune to Participate in Stifel Cardiometabolic Forum

Indeterminate GlobeNewswire

4 hours ago

Adaptyx Biosciences Granted FDA Breakthrough Device Designation For Its Continuous Cortisol Monitoring Technology and Is Accepted into FDA’s Total Product Life Cycle Advisory Program

Indeterminate GlobeNewswire

4 hours ago

Clearmind Enhances U.S. IP Presence with Publication of Three Patent Applications Covering LSD, Ketamine and Ibogaine Combinations

Indeterminate GlobeNewswire

5 hours ago

Acoramidis Demonstrates Real-World Benefit Versus Tafamidis in ATTR-CM, Reducing Risk of Clinical Worsening

Indeterminate GlobeNewswire

5 hours ago

Artelo Biosciences Files New Provisional Patent Application Covering ART27.13 for Obesity, Alone and in Combination with GLP-1 Receptor Agonists, Following Unexpected Nonclinical Findings

Indeterminate GlobeNewswire

5 hours ago

Entente Education Canada urges federal government to take steps to improve cash flow and tax fairness for seniors, caregiver support

Indeterminate GlobeNewswire

5 hours ago

Wave Life Sciences Initiates Phase 2a Combination Trial of WVE-007 (GalNAc-siRNA) with Tirzepatide for Obesity

Indeterminate GlobeNewswire

5 hours ago

Artiva Biotherapeutics Announces Oral Presentation of AlloNK® Clinical Data at the 17th International Symposium on Sjögren’s Disease

Indeterminate GlobeNewswire

5 hours ago

Biomea Fusion Announces Termination of Proposed Public Offering of Securities

Indeterminate GlobeNewswire

5 hours ago

AC Immune Reports Positive Safety & Immunogenicity at week-100 in Part 1 of VacSYn Phase 2 Trial of ACI-7104

Indeterminate GlobeNewswire